DISPARITIES IN STAGE-APPROPRIATE THERAPY FOR RESECTABLE NON-SMALL CELL LUNG CANCER IN KENTUCKY by Martin, Jeremiah T.
University of Kentucky 
UKnowledge 
Theses and Dissertations--Clinical Research 
Design College of Public Health 
2017 
DISPARITIES IN STAGE-APPROPRIATE THERAPY FOR 
RESECTABLE NON-SMALL CELL LUNG CANCER IN KENTUCKY 
Jeremiah T. Martin 
University of Kentucky, martinjt@somc.org 
Author ORCID Identifier: 
https://orcid.org/0000-0002-0666-2617 
Digital Object Identifier: https://doi.org/10.13023/ETD.2017.251 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Martin, Jeremiah T., "DISPARITIES IN STAGE-APPROPRIATE THERAPY FOR RESECTABLE NON-SMALL 
CELL LUNG CANCER IN KENTUCKY" (2017). Theses and Dissertations--Clinical Research Design. 1. 
https://uknowledge.uky.edu/crd_etds/1 
This Master's Thesis is brought to you for free and open access by the College of Public Health at UKnowledge. It has 
been accepted for inclusion in Theses and Dissertations--Clinical Research Design by an authorized administrator of 
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my thesis or dissertation and abstract are my original work. Proper attribution 
has been given to all outside sources. I understand that I am solely responsible for obtaining 
any needed copyright permissions. I have obtained needed written permission statement(s) 
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing 
electronic distribution (if such use is not permitted by the fair use doctrine) which will be 
submitted to UKnowledge as Additional File. 
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and 
royalty-free license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless an embargo applies. 
I retain all other ownership rights to the copyright of my work. I also retain the right to use in 
future works (such as articles or books) all or part of my work. I understand that I am free to 
register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of 
the program; we verify that this is the final, approved version of the student’s thesis including all 
changes required by the advisory committee. The undersigned agree to abide by the statements 
above. 
Jeremiah T. Martin, Student 
Dr. David Mannino, Major Professor 
Dr. David Mannino, Director of Graduate Studies 
  
  
DISPARITIES IN STAGE-APPROPRIATE THERAPY  
FOR RESECTABLE NON-SMALL CELL LUNG CANCER  
IN KENTUCKY 
 
THESIS 
 
Copyright © Jeremiah Thomas Martin 2016 
 
A thesis submitted in partial fulfillment  
of the requirements for the degree of 
Master of Science in Clinical Research Design (MSCRD) 
in the University of Kentucky College of Public Health 
 
By  
Jeremiah T. Martin 
 
Lexington, Kentucky  
 
Director: Dr. David Mannino,  
Professor & Chair  
(Preventive Medicine & Environmental Health) 
Lexington, Kentucky 
 
2016 
 
 
 
  
 
ABSTRACT OF THESIS 
 
DISPARITIES IN STAGE-APPROPRIATE THERAPY  
FOR RESECTABLE NON-SMALL CELL LUNG CANCER  
IN KENTUCKY 
Lung cancer (NSCLC) is the leading cause of cancer related mortality. Lung cancer 
screening aims to detect treatable cancers, however survival advantage will only be seen 
with early and appropriate stage-directed therapy. This study aims to understand recent 
rates of therapy for early-stage lung cancer in Kentucky, and to explore potential sources 
of disparities in treatment and outcomes. A Kentucky Cancer Registry query was 
performed of all NSCLC cases treated in the state from 2005-2014. Of 39,763 lung 
cancer patients, 10,622 were clinically operable. Of these, overall 40% did not receive 
surgery, while 16% did not receive any stage-appropriate local therapy. Wide variation 
was noted in rates of surgery and local therapy at the county level. Increased age, non-
private insurance status, non-white race, male gender, and non-married status were less 
likely to receive surgery. Median survival in patients who underwent surgery was 59.1 
months vs 16 months (p<0.001).  Appropriate stage-directed local therapy is a very 
important factor in survival of patients with early stage NSCLC. County-level variation 
in rates of therapy need further study. Demographic factors continue to drive disparities 
in therapy and outcomes in Kentucky and should inform health policy and ongoing 
research and education efforts. 
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INTRODUCTION 
Lung cancer is the leading cause of cancer-related mortality in the United States. It 
accounts for more cancer-related deaths than the next four causes of cancer combined for 
both genders.[1] Despite this, the overall survival from lung cancer remains poor and has 
not advanced significantly over the past several decades. 
The primary risk factor for the development of lung cancer is smoking.[2] Genetics, other 
occupational exposure, and prior cancers also play a role. Lung cancer develops when 
normal lung tissue becomes abnormal and begins to proliferate. Due to differences in 
treatment and behavior, lung cancers are divided into “small cell” and “non-small cell 
lung cancer”. The most common type of lung cancer is non-small cell lung cancer, and is 
the one which will be discussed in this project. 
Lung cancer is generally without symptoms until more advanced stages. The most 
common stage of presentation of lung cancer is stage 3, at which point treatment is 
generally supportive with chemotherapy and radiation delivering overall survival of less 
than 15% at 5 years. Over the past several decades multiple efforts have been made to 
develop a screening tool for lung cancer, however it was not until the arrival of the low-
dose CT screening programs that it was possible to potentially detect early stage lung 
cancer.[3] 
Reduction of mortality from lung cancer is a complex task. It requires risk factor and 
lifestyle modification for prevention, effective early detection mechanisms to find early-
stage cancers, and complex multidisciplinary teams to quickly and effectively treat 
cancers when found. 
When lung cancer is detected or suspected, early referral to a thoracic surgeon is 
important. The surgeon, in conjunction with the team at a cancer center, will make a 
determination as to be clinical stage of the patient. In early-stage cancer (1 and 2) the 
primary treatment should be a local therapy. This is ideally a lobectomy for a surgical 
candidate, or stereotactic radiation for a nonsurgical patient. Patients with stage 2 cancer 
may require chemotherapy in the adjuvant setting. 
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The initial workup of the cancer patient generally includes a brain MRI and PET scan to 
screen for metastatic disease. In the absence of distant metastasis, examination of the 
mediastinal lymph nodes checks for central nodal involvement. Finally, if the tumor is 
anatomically resectable, surgery is recommended if the patient's cardiopulmonary reserve 
can tolerate this. 
This initial decision making pathway is complex. It involves many variables which can 
be measured, but also relies on the clinical best judgment of the surgical team and staff at 
the cancer center. 
As screening programs become more prevalent, it is likely that more patients with early-
stage cancer will be identified. In order for lung cancer screening to therefore 
demonstrate a survival advantage, it is important that these early-stage patients receive 
optimal treatment. 
The objective of the current study is to  
1) determine the state-wide rates of surgery and local therapy in patients with  
early-stage lung cancer,  
2) to investigate the impact of appropriate local therapy on survival, and 
3) to determine the relative importance of socioeconomic disparities in the 
receipt of appropriate surgery, and on survival. 
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METHODS 
Data Source 
The Kentucky Cancer Registry (KCR) was chosen as the data source for the study. The 
KCR is an active surveillance registry of cancer cases in the state of Kentucky. Data are 
collected from multiple sources. On-site data abstractors collect and complete patient 
records, pathology information is transmitted electronically to the KCR, and periodic 
audits and reviews of data completeness and accuracy are performed. KCR records the 
full address of origin of each patient, and these data were extracted at the individual level: 
KCR staff collapsed these data to the county level and provided county-level linkage with 
socioeconomic data from the 2010 census. 
University of Kentucky Institutional Review Board Approval was obtained: This study 
was deemed IRB exempt as a retrospective review of existing data collected in a registry. 
Variables and selection criteria 
The KCR was queried for records to include years 2005-2014. All patients with Non-
Small Cell Lung Cancer diagnosis were extracted (Site Codes c340-c349 define 
carcinoma of the lung and bronchus; Small cell histology codes 8041-8045 were 
excluded) Demographic variables included age at diagnosis, year of diagnosis, marital 
status, gender, race, smoking status, insurance. Socioeconomic variables included county 
of residency, % of population graduating with high-school diploma in 2010, % of 
population below the poverty line in 2010. Clinical variables included tumor site and 
size, clinical T (tumor), clinical N (nodes), clinical M (metastasis), computed best stage 
based on AJCC clinical and pathological stages, class of case (referral), tumor grade, first 
course treatment, cancer sequence number, ICD-O-3 histology codes. A composite 
treatment code was used to determine the initial choice of treatment in each case. Follow-
up variables included date of last contact and vital status. 
The data were first grouped using a “Clinically Operable” categorical variable 
(CLINOP). This was constructed using an algorithm that mirrors that used in the cancer 
clinic by a thoracic surgeon. A patient is presumed to be operable until an exclusion is 
found. Starting with (M)etastasis, checking (N)odal involvement and finally (T)umor 
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resectability. If a patient was missing data in any or all of these counts, they were given 
the “benefit of the doubt” which is an accepted standard in the workup of cancer patients. 
This new CLINOP variable was compared with the KCR’s “best stage group”, and both 
were used to select data subsets for further analysis. These are the potentially operable, 
early stage, cohorts. 
The composite treatment variable was now used to stratify the patients into two different 
comparison groups: The groups that received surgery (SURG) vs no surgery, and the 
groups that received local therapy (LOCAL) vs no local therapy. Local therapy was 
defined as surgery or radiation or combination as first-line therapy. 
Statistical Methods 
All statistical analysis was conducted using the R Environment for Statistical 
Computing.[4]  
Numerical continuous variables were analyzed using descriptive statistics such as median 
and inter-quartile range. Categorical variables were reported as frequencies and 
percentages.  
After initial data exploration (Figure 1), statistical learning (decision tree) was used to 
search for potential predictors of whether or not a patient would receive surgery, based on 
the available input variables. The dataset was divided into a 70/30 training/test dataset 
and a conditional decision tree was constructed. (Figure 2).  
Descriptive statistics were generated for each group (Table 1). Logistic regression was 
used to measure the associations between demographic and socioeconomic predictors on 
the receipt of surgery (Table 2). A multivariate logistic model was constructed using 
forward selection. 
Survival was examined using Kaplan-Meier estimates, and stratifying the patients into 
SURG/LOCAL groups in addition to demonstrating the effects in both the CLINOP 
group and the KCR Best Stage cohort (Table 3). Cox Proportional Hazards models were 
constructed to calculate unadjusted univariate Hazard Ratios for long-term survival based 
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on receipt of surgery vs local therapy and a multivariate Cox Proportional Hazards model 
returned adjusted Hazard Ratios. (Table 4) 
Finally, although individual county-level measurements did not reach statistical 
significance on multivariate modeling, there appear to be wide variations in the rates at 
which patients receive surgery. These rates were tabulated and graphically represented to 
facilitate future discussion and study. (Table 5, Figure 3) 
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RESULTS 
Description of the dataset, initial exploration 
The KCR query returned 39,763 patients with NSCLC in the study period 2005-2014. 
The initial stratification revealed cohorts of 10,622 clinically operable patients, and 
11,274 KCR best stage. Since the intent was to analyze early within the decision tree, and 
much of the analysis focused on the clinically operable group.  
Within the clinically operable group, overall 40% (4,203) patients did not receive 
surgery. Stage appropriate local therapy includes radiation to patients who may be poor 
candidates for surgery however within the clinical stage 1 and 2 group, 16% (1736) did 
not receive stage appropriate local therapy (Table 1). Although the Registry does not 
contain details on comorbidities, there remained important differences in demographic 
and socioeconomic variables between patients who received surgery or local therapy 
versus suboptimal therapy. Univariate analysis demonstrated that more married patients 
received surgery or local therapy compared to single or divorced. White race and female 
gender accounted for more of the surgically and locally treated patients. The presence of 
private insurance and Medicare accounted for more of the treated patients compared with 
self-pay, Medicaid, or military or other government insurance. Univariate differences 
were not identified when stratifying the county of residence as appalacian vs not, rural vs 
not, or based on percentage of population graduating high school, or percentage of the 
population below the poverty line.  
Figure 1 graphically illustrates some differences between Appalachian Counties versus 
the remainder of the state. There are expected differences in rates of high school 
graduation, and percent below the poverty line. Breakdown of insurance coverage is 
different within these regions, however smoking and surgery rates do not appear visually 
different. 
Statistical Learning 
Prior to building a logistic regression model, a conditional decision tree was built 
including the demographic and socioeconomic inputs to recursively stratify the 
population based on whether or not surgery was received. Figure 2 illustrates these 
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findings. Age of diagnosis is the most important factor, with a split point of 78 years 
representing an initial partition of the data between those who did, versus did not receive 
surgery. Amongst the younger patients, insurance was the next most important partition 
point for those patients less than 61, while marital status was more important for patients 
greater than 61. This decision tree was developed on a training dataset derived from a 
random sample of 80% of the clinically operable patients. The model was tested on the 
remaining 20% with a 34% overall error rate, and AUC of 0.6745. 
Factors associated with Receipt of Surgery 
Logistic regression was used to determine the individual and relative strengths of 
association between the available variables and receipt of surgery. Findings are 
summarized in Table 2. Univariate odds ratios were generated by running individual 
regression models for the variable of interest with the outcome of surgery. Forward 
selection based on reduction of AIC was used to generate a final fitted logistic model. 
The AUC for the final fitted logistic model was 0.693 
Patients who are older were less likely to have received surgery (OR 0.94 per year, 95% 
CI 0.93-0.94, p<0.001). Patients who were married were more likely to have received 
surgery (OR 1.59 vs single, 95% CI 1.33-1.89, p<0.001). Patients with private insurance 
(OR 1.42) and Medicare (OR 1.42) were more likely than self-pay or uninsured to have 
received surgery however patients with Medicaid (OR 0.65) or military/government (OR 
0.52) insurance were less likely to have received surgery than self-pay or uninsured. 
Patients whose cancer diagnosis was rendered at a site other than treating facility were 
much less likely to have received surgery (OR 0.13, 95% CI 0.07-0.27, p<0.001) 
There is also a time-related trend in surgery: compared with 2005, the odds of having 
received surgery in the adjusted model increased to a peak of 2.06 in 2011, before 
decreasing towards 1.48 in 2014. 
Smoking history (OR 0.6, 95% CI 0.5-0.73, p<0.001), female gender (OR 1.27, 95% CI 
1.15-1.4, P<0.001), and white race (OR 1.47, 95% CI 1.22-1.79, 95% CI P<0.001) also 
contributed to the final model. 
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Geographic socioeconomic factors including Appalachia vs not, urban/rural continuum, 
% population below poverty line, and % population graduating high school, did not 
remain significant in the final adjusted model. 
Factors associated with Survival 
Kaplan-Meier analysis was performed on the derived clinically operable cohort in 
addition to the KCR “Best Stage” cohort. This analysis was stratified based on whether or 
not surgery was performed, and whether or not local therapy was used. 
In all cases, surgery or local therapy was associated with significant survival differences. 
In the clinically operable cohort, the median survival in patients who underwent surgery 
was 59.1 months vs 16 months (p<0.001) . The median survival among patients who 
underwent any local therapy (surgery or radiation) was 44.15 months vs 8.61 months 
(p<0.001). (Table 3) 
Cox proportional hazards regression models were performed at the individual variable 
level and factors found to be significant were chosen and entered into two final adjusted 
models (Table4). The first model was adjusted for significant covariates, and included the 
primary outcome of surgery vs not. The hazard ration for surgery of 0.37 (95% CI 0.35-
0.39, p<0.001) was the strongest association with improved survival when controlling for 
the other factors in the model. Female gender (HR 0.71, 95% CI 0.67-0.75, p<0.001), 
Insurance Status (Medicaid HR 1.23, 95% CI 1.07-1.42, p=0.005), and age at diagnosis 
(HR 1.02 p<0.001) also retained significant independent association with decreased 
survival in the final adjusted model. 
A second multivariable model, adjusted for local therapy vs not, had a hazard ratio for 
local therapy of 0.32 (95% CI 0.3-0.34, p<0.001) which again was the strongest factor 
associated with survival. Female gender, age at diagnosis, and insurance status again 
remained significant in the final model. Marital status (Married HR 0.9, 95% CI 0.81-
0.99, p=0.028) also remained significant in this model. 
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State-wide variation in rates of surgery 
There are differences in the proportions of patients who undergo surgery, local therapy, 
and survival rates at the county level in the State of Kentucky throughout the study 
period. In multivariate modeling, these differences were not found to be statistically 
significant, however this pattern warrants further study. 
Findings are visually illustrated in Figure 3. Table 5 identifies counties with the lowest 
and highest rates of surgery and local therapy and reports overall and surgical survival for 
these patients. Rates of surgery in early stage lung cancer vary from 36% in Leslie 
county, to 80% in Robertson county. Meanwhile local therapy ranges from 39% in Elliott 
county to 100% in Robertson county.  
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DISCUSSION 
Lung cancer is a highly lethal disease. The primary risk factor of smoking is highly 
prevalent, public awareness still needs work, and many times the disease is not identified 
until it is significantly advanced. Screening programs using low-dose computed 
tomography will hopefully affect a stage-shift with earlier detection of lung cancer, 
however once cancers have been found in order to affect survival we need to ensure that 
timely and appropriate stage directed therapy is performed. 
Researchers are increasingly concerned with disparities in healthcare, and in the case of 
cancer care disparities a significantly higher mortality is seen in disadvantaged groups. In 
his editorial, “Deprivation, distance and death and lung cancer,” Dr. Peake summarizes 
recent literature on the topic and makes the point that it must be our, “aim to find ways of 
ensuring equitable access to the highest quality of care for all patients with lung cancer 
were ever they live and whether further social background.”[5] 
This study of registry-level data demonstrates that there are differences in rates of surgery 
and local therapy throughout the state of Kentucky. In addition, multivariate analysis 
demonstrates that whether or not surgery or local therapy is received is also affected by 
gender, race, and insurance disparities. This is in keeping with findings from other 
studies.[6-17] Interestingly, the current analysis fails to demonstrate significantly 
different survival in patients from various parts of the state. This may in part be due to the 
magnitude of the effect of surgery vs. not on survival, which may mask the much smaller 
effect of geographic disparity. A longer study period with larger patient population size 
may further help to delineate this. In addition, the current analysis is limited to those 
patients were diagnosed with clinically stage 1 and 2 cancer and therefore excludes the 
likelihood that patients in rural centers may present more advanced stages of disease. 
The impact of insurance status on outcomes, which include not only receipt of surgery or 
local therapy but also survival, is an important public health concern. This trend and 
association which is demonstrated in the analysis of this dataset was also found in 
analysis of a national sample. Shi and colleagues[7] found in an analysis of the National 
Cancer Data Base that Medicaid and uninsured patients are at a higher risk mortality than 
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patients with private insurance. They hypothesized that these disparities may be due to 
different treatments offered based on insurance status which is also seen in this analysis. 
Statistical learning techniques demonstrated one of the most important factors in 
determining whether or not surgery was offered was age, and a split point of 78 years was 
identified. Recent literature would indicate that older patients can enjoy long term 
survival after cancer surgery[18], and therefore this should be kept in mind by physicians 
treating these patients.  
The yearly odds of receiving surgery for stage 1 and 2 lung cancer demonstrated 
improvement until 2011 with a later decline of unclear importance. Factors which likely 
impact this include changes in insurance policies around that time, and the increasing 
application of stereotactic radiation (SBRT) for clinical stage 1 and 2 cancers.[19] While 
the initial outcomes associated with SBRT are promising, the oncologic efficacy remains 
to be proven in long term followup. This trend should be closely monitored to ensure that 
patients continue to receive optimal treatment. 
The regional variations in cancer surgery rates are likely driven by availability of and 
access to healthcare resources. Smith and colleagues analyzed the travel patterns of 
cancer surgery patients in a regionalized system. They found that regionalization had 
significantly increased the distance that some patients must travel to receive their surgical 
care.[20] Comprehensive care of the cancer patient requires multidisciplinary evaluation 
including availability of radiologists, surgeons, medical and radiation oncologists, and a 
facility that can support all of these providers. In the present area, referral patterns may 
be driven by insurance, hospital networks, and provider and patient bias. Ideally, 
networks of high-quality care centers will work together to optimize outcomes. 
An analysis of the National Inpatient Sample demonstrated that non-white race and 
comorbidities contributed to increased likelihood of receiving cancer surgery at low-
volume hospitals.[21] This is an important consideration as hospitals that infrequently 
treat lung cancer may be less likely to have the full support network in place to provide 
optimal multidisciplinary care. In the state of Kentucky, travel distances involved for 
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patients to reach accredited cancer centers, or academic facilities, may be prohibitive for 
many with limited means. 
Public Health Implications 
Disparities in healthcare are a major public health concern. These factors account for up 
to 25% of the variations in outcome in morbidity and mortality in this country.[22, 23] 
The issues stem from many areas and there are individual actionable items. Ongoing 
efforts in all of these domains will improve outcomes in lung cancer therapy and 
ultimately survival. These areas, and their particular application to lung cancer in 
Kentucky, can be broadly broken down as follows: 
1. Health System Related 
a. Access 
b. Quality 
c. Regulations, Policies and Systems 
2. Patient Related 
a. Patient preferences, compliance 
b. Culture, Lifestyle 
c. Biology and genetics 
3. Provider Related 
a. Prejudice, bias 
b. Up-to-date knowledge 
c. Cultural insensitivities 
In this analysis of the Kentucky Cancer Registry, there are several statistically significant 
points that lend to action items and further study. 
1) Receipt of Local Therapy or Surgery vs none 
This was the single most important predictor of survival and the rates of local 
therapy or surgery vary widely based on the county of origin and are affected by 
insurance status, age, race, gender. In addition to being driven by patient beliefs 
and education, there is an opportunity to educate providers across the healthcare 
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continuum about the importance of early stage-directed therapy for patients with 
clinical stage 1 and 2 lung cancer. These efforts might yield the most benefit in 
counties where the rates of such therapy are low. The precise reasons for county-
wide variation in surgery or local therapy cannot be extrapolated from the current 
data set but deserve further study.  
2) Age 
Older patients are less likely to receive curative intent surgery or local therapy. 
Educating provders and patients that age alone should not exclude from receipt of 
maximal therapy may decrease the impact of this factor. 
3) Insurance 
Paying for care continues to be a major public health problem – a patient’s ability 
to pay will affect their seeking timely care, and their choices when treatment 
options are presented. Payer status may indirectly affect physician’s decision 
making as cancer care requires a team effort with multiple visits and close 
followup. Raising the awareness of the impact of this factor on both treatment and 
survival outcomes is an important first step. 
4) Race 
Kentucky’s ethnic distribution may make it more difficult for minority groups to 
seek, understand, and benefit from complex care. Education of providers, and 
targeting at-risk populations to increase awareness of lung cancer screening 
programs may help these groups. 
 
Limitations 
There are a number of important limitations of the current study. First, this represents a 
retrospective analysis of registry level data. Much of this data is collected retrospectively 
from chart review. Pathology information is accurate, however clinical staging 
information relies on documentation of the physicians caring for the patients, and 
sometimes this is less accurate. When a patient undergoes surgery, complete pathologic 
staging is available which is much more accurate but not directly applicable to this study: 
When the Registry “best stage” variable was used to examine the data, additional stage 1 
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and 2 patients were found who underwent surgery who were missing clinical staging 
information. However, to remain as close as possible to what would occur in clinicians 
office, only available clinical staging information was used. 
Survival difference was not noted to be significant when stratifying patients based on 
county of origin. It is likely that selecting only clinical stage 1 and 2 patients introduced 
bias in this regard. It is probable that more patients with advanced disease are diagnosed 
in underserved areas however the purpose of the study was to specifically look at rates of 
surgery in early-stage patients therefore this was not further explored and warrants further 
investigation. 
Data are not available on some of the important clinical comorbidities which a surgeon 
may use to determine whether or not to offer surgery. In addition the intrinsic bias of the 
physician and patient during the clinical encounter cannot be measured or recorded and 
are absent from this analysis.  
Future directions 
There are indications from the current study that rates of local therapy are changing over 
time, and that there are wide variations in rates at the county level. Ongoing surveillance 
of these datapoints is needed and cancer prevention efforts should continue to focus on 
at-risk populations including underserved counties.  
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CONCLUSION 
In patients with clinically stage 1 and 2 lung cancer in Kentucky, there is wide variation 
in the rate of curative-intent locally-directed therapy. Receipt of stage appropriate local 
therapy is the strongest predictor of survival. Race, Gender, Insurance and Marital Status 
are important demographic factors that contribute to disparities in treatment and outcome.  
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Table 1:  
Descriptive statistics, and univariate analysis. Stage appropriate surgery is defined as 
surgery as part of the initial course of therapy for clinically stage 1 and 2 lung cancer 
patients. Stage appropriate local therapy includes surgery and radiation therapy as part of 
the initial course of therapy.  
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OR 95% CI p-value OR 95% CI p-value
Age 0.94 (0.94 - 0.95) <0.001 0.94 (0.93 - 0.94) <0.001
Marital Status (%) Single ref ref
Married 1.37 (1.17 - 1.61) <0.001 1.59 (1.33 - 1.89) <0.001
Separated 1.18 (0.71 - 1.95) 0.526 1.03 (0.6 - 1.76) 0.914
Divorced 1.01 (0.84 - 1.22) 0.881 1 (0.82 - 1.23) 0.982
Widowed 0.64 (0.54 - 0.76) <0.001 0.96 (0.79 - 1.17) 0.660
Unmarried 0.53 (0.21 - 1.36) 0.189 0.53 (0.2 - 1.42) 0.205
Insurance (%) Self-pay, none ref ref
Private insurance 1.47 (1.19 - 1.83) <0.001 1.42 (1.13 - 1.79) 0.003
Medicaid 0.63 (0.5 - 0.8) <0.001 0.65 (0.51 - 0.84) 0.001
Medicare 0.55 (0.46 - 0.66) <0.001 1.22 (1 - 1.49) 0.054
Military , govt 0.31 (0.22 - 0.45) <0.001 0.52 (0.35 - 0.75) 0.001
Diagnosis Elsewhere 0.14 (0.07 - 0.27) <0.001 0.13 (0.07 - 0.27) <0.001
Year of Diagnosis 2005 ref ref
2006 1.23 (0.94 - 1.62) 0.130 1.27 (0.95 - 1.7) 0.101
2007 1.54 (1.17 - 2.02) 0.002 1.58 (1.18 - 2.1) 0.002
2008 1.81 (1.42 - 2.3) <0.001 1.88 (1.46 - 2.42) <0.001
2009 1.7 (1.34 - 2.16) <0.001 1.88 (1.46 - 2.42) <0.001
2010 1.82 (1.45 - 2.3) <0.001 1.92 (1.5 - 2.45) <0.001
2011 1.83 (1.45 - 2.3) <0.001 2.06 (1.62 - 2.63) <0.001
2012 1.44 (1.14 - 1.81) 0.002 1.47 (1.16 - 1.87) 0.002
2013 1.49 (1.19 - 1.87) 0.001 1.59 (1.25 - 2.03) <0.001
2014 1.36 (1.08 - 1.7) 0.008 1.48 (1.17 - 1.88) 0.001
Smoking History 0.68 (0.57 - 0.82) <0.001 0.6 (0.5 - 0.73) <0.001
Female Gender 1.15 (1.05 - 1.25) 0.002 1.27 (1.15 - 1.4) <0.001
White Race 1.47 (1.23 - 1.76) <0.001 1.47 (1.22 - 1.79) <0.001
Left sided tumor 0.9 (0.83 - 0.98) 0.020 0.91 (0.83 - 1) 0.044
% pop below poverty 1 (0.99 - 1.01) 0.537 0.99 (0.99 - 1) 0.123
% pop grad HS 0.99 (0.99 - 1) 0.079
Urban / Rural Continuum 1 ref
2 1.23 (1.06 - 1.43) 0.006
3 1.13 (0.97 - 1.31) 0.105
4 1.1 (0.86 - 1.39) 0.450
5 0.99 (0.77 - 1.27) 0.961
6 1.38 (1.19 - 1.61) <0.001
7 1.16 (1.02 - 1.33) 0.025
8 1.31 (1.04 - 1.67) 0.025
9 1.04 (0.88 - 1.24) 0.643
Appalacia vs not 1.09 (0.99 - 1.2) 0.073
Unadjusted Adjusted
Table 2:  
Unadjusted and multivariate adjusted odds ratios for receipt of surgery. The AUC for the 
fitted model is 0.693 
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Table 3:  
Kaplan-Meier survival analysis. Curves and median survivals are shown for surgery vs 
not, and local therapy vs not in both the clinically operable group (CLINOP) and the 
KCR “Best Stage” group.  
 
 
Clinically Operable Cohort  KCR Best Stage Cohort 
   
   
        
 n events median  n events median 
surg=0 4203 3344 16  surg=0 4011 3253 16.4 
surg=1 6419 3111 59.1  surg=1 7263 3760 61.8 
         
   
   
        
 n events median  n events median 
local=0 1736 1531 8.61  local=0 1733 1551 9.8 
local=1 8886 4924 44.15  local=1 9541 5462 48.2 
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HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value
Surgery vs No Surgery 0.33 (0.31 - 0.34) <0.001 0.37 (0.35 - 0.39) <0.001
Local Therapy vs None 0.28 (0.26 - 0.29) <0.001 0.32 (0.3 - 0.34) <0.001
Urban / Rural Continuum 1 ref
2 1.02 (0.94 - 1.11) 0.582
3 0.96 (0.88 - 1.04) 0.318
4 1.16 (1.02 - 1.33) 0.029
5 1.06 (0.91 - 1.22) 0.454
6 1.02 (0.94 - 1.11) 0.595
7 1.06 (0.98 - 1.14) 0.132
8 1.00 (0.88 - 1.14) 0.995
9 1.12 (1.01 - 1.23) 0.028
Appalacia vs Not 1.09 (1.03 - 1.15) 0.002 1.07 (0.99 - 1.17) 0.092 1.06 (0.98 - 1.15) 0.139
Female vs Male 0.74 (0.7 - 0.78) <0.001 0.71 (0.67 - 0.75) <0.001 0.7 (0.67 - 0.74) <0.001
Age at Diagnosis 1.03 (1.03 - 1.04) <0.001 1.02 (1.02 - 1.02) <0.001 1.03 (1.02 - 1.03) <0.001
% pop grad HS 1.00 (0.99 - 1) 0.003 1.00 (0.99 - 1) 0.182 1.00 (0.99 - 1) 0.319
% pop below poverty 1.01 (1 - 1.01) 0.02 1.00 (0.99 - 1.01) 0.475 1.00 (0.99 - 1.01) 0.567
White Race vs NonWhite 1.04 (0.94 - 1.16) 0.428 1.04 (0.93 - 1.16) 0.485 1.04 (0.94 - 1.17) 0.431
Diagnosis elsewhere vs not 1.63 (1.28 - 2.09) <0.001 1.24 (0.96 - 1.61) 0.1 1.14 (0.88 - 1.48) 0.31
Insurance Self-pay, none ref ref ref
Private insurance 0.81 (0.72 - 0.92) 0.001 0.86 (0.75 - 0.97) 0.017 0.83 (0.73 - 0.94) 0.004
Medicaid 1.34 (1.17 - 1.54) <0.001 1.23 (1.07 - 1.42) 0.005 1.26 (1.09 - 1.45) 0.001
Medicare 1.55 (1.4 - 1.72) <0.001 1.06 (0.95 - 1.18) 0.333 1.01 (0.91 - 1.13) 0.842
Military , govt 1.55 (1.33 - 1.8) <0.001 0.95 (0.82 - 1.12) 0.561 1.05 (0.9 - 1.23) 0.506
Marital Status Single ref ref ref
Married 0.95 (0.86 - 1.05) 0.299 0.94 (0.85 - 1.03) 0.196 0.9 (0.81 - 0.99) 0.028
Separated 1.04 (0.77 - 1.4) 0.816 1.13 (0.84 - 1.52) 0.432 1.06 (0.79 - 1.43) 0.696
Divorced 1.10 (0.98 - 1.23) 0.093 1.14 (1.02 - 1.27) 0.024 1.10 (0.99 - 1.23) 0.086
Widowed 1.31 (1.19 - 1.46) <0.001 1.11 (0.99 - 1.24) 0.065 1.08 (0.97 - 1.2) 0.173
Unmarried 1.34 (0.72 - 2.51) 0.36 1.07 (0.57 - 2.01) 0.827 1.00 (0.53 - 1.87) 0.992
Unadjusted Adjusted,  inc. surgery Adjusted, inc. local therapy
Table 4:  
Unadjusted and adjusted multivariate cox proportional hazard models for survival. 
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Figure 1 
Graphical exploration of some of the factors that may be important in determining outcomes 
differences between patients who live in appalacian counties versus not. 
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Figure 3 
Choropleth representation of rates of surgery and local therapy by county in the state of 
Kentucky over the 10 year study period. 
 
 
 
 
 
  
25 
 
REFERENCES 
1. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2016. CA Cancer J Clin, 2016. 
66(1): p. 7-30. 
2. Boyle, J.M., et al., Smoking history predicts for increased risk of second primary lung 
cancer: a comprehensive analysis. Cancer, 2015. 121(4): p. 598-604. 
3. National Lung Screening Trial Research, T., et al., Reduced lung-cancer mortality with 
low-dose computed tomographic screening. N Engl J Med, 2011. 365(5): p. 395-409. 
4. R Development Core Team, R: A language and environment for statistical computing. 
2016, R Foundation for Statistical Computing: Vienna, Austria. 
5. Peake, M.D., Deprivation, distance and death in lung cancer. Thorax, 2015. 70(2): p. 
108-9. 
6. Koshy, M., et al., Disparities in treatment of patients with inoperable stage I non-small 
cell lung cancer: a population-based analysis. J Thorac Oncol, 2015. 10(2): p. 264-71. 
7. Shi, R., et al., The Effect of Payer Status on Survival of Patients with Stage I/II Non-small 
Cell Lung Cancer: NCDB 1998-2011. Anticancer Res, 2016. 36(1): p. 319-26. 
8. Okamoto, J., H. Kubokura, and J. Usuda, Factors Determining the Choice of Surgical 
Procedure in Elderly Patients with Non-Small Cell Lung Cancer. Ann Thorac Cardiovasc 
Surg, 2016. 22(3): p. 131-8. 
9. Williams, C.D., et al., Influence of comorbidity on racial differences in receipt of surgery 
among US veterans with early-stage non-small-cell lung cancer. J Clin Oncol, 2013. 
31(4): p. 475-81. 
10. Samson, P., et al., The National Surgical Quality Improvement Program risk calculator 
does not adequately stratify risk for patients with clinical stage I non-small cell lung 
cancer. J Thorac Cardiovasc Surg, 2016. 151(3): p. 697-705 e1. 
11. Melvan, J.N., et al., Nonclinical Factors Associated with 30-Day Mortality after Lung 
Cancer Resection: An Analysis of 215,000 Patients Using the National Cancer Data 
Base. J Am Coll Surg, 2015. 221(2): p. 550-63. 
12. Sher, D.J., M.J. Liptay, and M.J. Fidler, Prevalence and predictors of neoadjuvant 
therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: 
importance of socioeconomic status and treating institution. Int J Radiat Oncol Biol 
Phys, 2014. 89(2): p. 303-12. 
26 
 
13. Weksler, B., et al., Racial and Ethnic Differences in Lung Cancer Surgical Stage: An STS 
Database Study. Thorac Cardiovasc Surg, 2015. 63(7): p. 538-43. 
14. Poghosyan, H., et al., Racial Disparities in Health-Related Quality of Life After Lung 
Cancer Surgery: Findings From the Cancer Care Outcomes Research and Surveillance 
Consortium. J Thorac Oncol, 2015. 10(10): p. 1404-12. 
15. Corso, C.D., et al., Racial disparities in the use of SBRT for treating early-stage lung 
cancer. Lung Cancer, 2015. 89(2): p. 133-8. 
16. Harrison, M.A., et al., Racial disparity in in-hospital mortality after lobectomy for lung 
cancer. Am J Surg, 2015. 209(4): p. 652-8. 
17. Tong, B.C., et al., Sex differences in early outcomes after lung cancer resection: analysis 
of the Society of Thoracic Surgeons General Thoracic Database. J Thorac Cardiovasc 
Surg, 2014. 148(1): p. 13-8. 
18. Eguchi, T., et al., Impact of Increasing Age on Cause-Specific Mortality and Morbidity in 
Patients With Stage I Non–Small-Cell Lung Cancer: A Competing Risks Analysis. Journal 
of Clinical Oncology. 0(0): p. JCO690834. 
19. Crabtree, T.D., et al., Analysis of first recurrence and survival in patients with stage I 
non-small cell lung cancer treated with surgical resection or stereotactic radiation 
therapy. J Thorac Cardiovasc Surg, 2014. 147(4): p. 1183-1191; discussion 1191-2. 
20. Smith, A.K., et al., Travel patterns of cancer surgery patients in a regionalized system. J 
Surg Res, 2015. 199(1): p. 97-105. 
21. Al-Refaie, W.B., et al., Who receives their complex cancer surgery at low-volume 
hospitals? J Am Coll Surg, 2012. 214(1): p. 81-7. 
22. McGinnis, J.M. and W.H. Foege, Actual causes of death in the United States. JAMA, 
1993. 270(18): p. 2207-12. 
23. Satcher, D. and E.J. Higginbotham, The public health approach to eliminating disparities 
in health. Am J Public Health, 2008. 98(3): p. 400-3. 
  
27 
 
APPENDIX 
 
1. Per-County Rates of surgery, local therapy, and survival 
2. R-Script for Data Analysis 
3. IRB document 
  
28 
 
SURGERY LOCAL	THERAPY
rate rate n events median n events median
21001 Adair Lake	Cumberland Rural 7 Appalachia 0.465 0.791 43 28 30.3 20 9 96.9
21003 Allen Barren	River Rural 6 Non-Appalachia 0.661 0.911 56 42 26.7 37 25 36.5
21005 Anderson Bluegrass Rural 6 Non-Appalachia 0.479 0.750 48 27 46 23 7 94
21007 Ballard Purchase Rural 9 Non-Appalachia 0.625 0.813 16 9 35 10 5 35
21009 Barren Barren	River Rural 6 Non-Appalachia 0.750 0.940 100 54 48.7 75 34 60.2
21011 Bath Gateway Rural 8 Appalachia 0.657 0.857 35 19 41.6 23 8 NA
21013 Bell Cumberland	Valley Rural 7 Appalachia 0.470 0.803 66 39 40.8 31 11 NA
21015 Boone Northern	Kentucky Urban 1 Non-Appalachia 0.572 0.827 173 101 34.9 99 46 58.6
21017 Bourbon Bluegrass Urban 2 Non-Appalachia 0.571 0.878 49 27 40.6 28 9 NA
21019 Boyd Fivco Urban 2 Appalachia 0.648 0.855 179 114 42.4 116 64 54.7
21021 Boyle Bluegrass Rural 7 Non-Appalachia 0.563 0.854 48 24 34.2 27 11 NA
21023 Bracken Buffalo	Trace Urban 1 Non-Appalachia 0.538 0.731 26 16 25.2 14 6 54
21025 Breathitt Kentucky	River Rural 7 Appalachia 0.557 0.836 61 43 26.8 34 22 45.5
21027 Breckinridge Lincoln	Trail Rural 8 Non-Appalachia 0.561 0.772 57 34 43.3 32 13 NA
21029 Bullitt Kipda Urban 1 Non-Appalachia 0.663 0.853 190 101 43.5 126 57 65.3
21031 Butler Barren	River Rural 8 Non-Appalachia 0.750 0.861 36 22 30.7 27 13 57.7
21033 Caldwell Pennyrile Rural 6 Non-Appalachia 0.571 0.971 35 26 22.4 20 15 28.9
21035 Calloway Purchase Rural 7 Non-Appalachia 0.607 0.845 84 55 28.7 51 26 61.7
21037 Campbell Northern	Kentucky Urban 1 Non-Appalachia 0.582 0.851 201 138 28.8 117 69 45.4
21039 Carlisle Purchase Rural 9 Non-Appalachia 0.455 0.818 11 9 13.8 5 3 68.4
21041 Carroll Northern	Kentucky Rural 6 Non-Appalachia 0.649 0.973 37 21 34.5 24 10 62.5
21043 Carter Fivco Rural 6 Appalachia 0.524 0.744 82 60 25.2 43 23 50
21045 Casey Lake	Cumberland Rural 9 Appalachia 0.583 0.833 36 22 33 21 9 42.5
21047 Christian Pennyrile Urban 3 Non-Appalachia 0.509 0.716 116 81 30 59 33 52.3
21049 Clark Bluegrass Urban 2 Appalachia 0.645 0.849 93 60 28.2 60 31 45.1
21051 Clay Cumberland	Valley Rural 7 Appalachia 0.611 0.833 36 21 34.5 22 8 NA
21053 Clinton Lake	Cumberland Rural 9 Appalachia 0.714 0.964 28 16 33.5 20 11 33.6
21055 Crittenden Pennyrile Rural 6 Non-Appalachia 0.647 1.000 17 11 33.6 11 6 33.6
21057 Cumberland Lake	Cumberland Rural 9 Appalachia 0.679 0.929 28 17 42.1 19 9 55.2
21059 Daviess Green	River Urban 3 Non-Appalachia 0.610 0.830 364 235 37 222 116 61.7
21061 Edmonson Barren	River Urban 3 Appalachia 0.683 0.854 41 24 36.5 28 14 39.9
21063 Elliott Fivco Rural 9 Appalachia 0.391 0.609 23 19 24.4 9 5 47.5
21065 Estill Bluegrass Rural 6 Appalachia 0.623 0.717 53 30 35.2 33 13 68.8
21067 Fayette Bluegrass Urban 2 Non-Appalachia 0.653 0.855 475 269 36.6 310 141 54
21069 Fleming Buffalo	Trace Rural 7 Appalachia 0.571 0.800 35 19 33.5 20 7 NA
21071 Floyd Big	Sandy Rural 7 Appalachia 0.540 0.758 161 104 28.5 87 45 56.6
21073 Franklin Bluegrass Rural 4 Non-Appalachia 0.550 0.775 120 83 23.1 66 40 34.7
21075 Fulton Purchase Rural 7 Non-Appalachia 0.667 0.667 18 11 36.8 12 6 63.4
21077 Gallatin Northern	Kentucky Urban 1 Non-Appalachia 0.783 0.870 23 13 50.4 18 8 79.1
21079 Garrard Bluegrass Rural 6 Appalachia 0.591 0.909 44 27 47.2 26 15 57.4
21081 Grant Northern	Kentucky Urban 1 Non-Appalachia 0.620 0.740 50 35 25.2 31 18 53.9
21083 Graves Purchase Rural 7 Non-Appalachia 0.685 0.959 73 48 43.8 50 31 53.9
21085 Grayson Lincoln	Trail Rural 6 Non-Appalachia 0.701 0.883 77 45 41.3 54 28 57.2
21087 Green Lake	Cumberland Rural 8 Appalachia 0.478 0.696 23 14 49.3 11 4 81.2
21089 Greenup Fivco Urban 2 Appalachia 0.588 0.840 119 81 30.5 70 40 44.4
21091 Hancock Green	River Urban 3 Non-Appalachia 0.600 0.880 25 13 46 15 5 66.3
21093 Hardin Lincoln	Trail Urban 3 Non-Appalachia 0.644 0.854 261 136 45.2 168 70 73.1
21095 Harlan Cumberland	Valley Rural 7 Appalachia 0.719 0.888 89 49 40.2 64 33 55.9
21097 Harrison Bluegrass Rural 6 Non-Appalachia 0.511 0.830 47 27 23.4 24 6 NA
21099 Hart Barren	River Rural 8 Appalachia 0.617 0.883 60 41 36.3 37 20 54.2
21101 Henderson Green	River Urban 2 Non-Appalachia 0.565 0.826 115 71 32.4 65 34 51.9
21103 Henry Kipda Urban 1 Non-Appalachia 0.595 0.881 42 28 22.8 25 13 80.7
21105 Hickman Purchase Rural 9 Non-Appalachia 0.429 0.786 14 13 20.5 6 6 30
21107 Hopkins Pennyrile Rural 4 Non-Appalachia 0.613 0.849 93 56 42.6 57 24 72.7
21109 Jackson Cumberland	Valley Rural 9 Appalachia 0.548 0.839 31 19 27.1 17 9 63.1
21111 Jefferson Kipda Urban 1 Non-Appalachia 0.552 0.821 1957 1140 35.7 1080 470 69.4
21113 Jessamine Bluegrass Urban 2 Non-Appalachia 0.588 0.765 85 52 29 50 24 42.4
21115 Johnson Big	Sandy Rural 7 Appalachia 0.438 0.672 64 42 29.5 28 13 47.9
21117 Kenton Northern	Kentucky Urban 1 Non-Appalachia 0.618 0.845 283 170 34.4 175 81 65.2
21119 Knott Kentucky	River Rural 9 Appalachia 0.569 0.843 51 35 18.6 29 15 50.4
21121 Knox Cumberland	Valley Rural 7 Appalachia 0.544 0.842 57 33 35.9 31 15 52.6
21123 Larue Lincoln	Trail Urban 3 Non-Appalachia 0.563 0.750 32 18 61.6 18 6 NA
21125 Laurel Cumberland	Valley Rural 7 Appalachia 0.730 0.921 89 49 43 65 32 43.8
21127 Lawrence Fivco Rural 6 Appalachia 0.590 0.795 39 22 40.4 23 11 58.4
21129 Lee Kentucky	River Rural 9 Appalachia 0.625 0.750 16 8 44.7 10 4 NA
21131 Leslie Kentucky	River Rural 9 Appalachia 0.364 0.697 33 22 24.4 12 5 NA
21133 Letcher Kentucky	River Rural 9 Appalachia 0.738 0.918 61 33 59.4 45 19 61.6
21135 Lewis Buffalo	Trace Rural 8 Appalachia 0.690 0.929 42 26 30.7 29 16 30.8
21137 Lincoln Bluegrass Rural 7 Appalachia 0.721 0.930 43 24 54.7 31 16 62.1
21139 Livingston Pennyrile Rural 9 Non-Appalachia 0.528 0.861 36 28 26 19 13 47.2
21141 Logan Barren	River Rural 6 Non-Appalachia 0.649 0.894 94 55 43.5 61 29 62.1
21143 Lyon Pennyrile Rural 8 Non-Appalachia 0.667 0.972 36 23 30.7 24 14 47.1
Overall	Survival Overall	Surgical	Survival
Per-County Rates 
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21145 McCracken Purchase Rural 5 Non-Appalachia 0.581 0.843 172 110 30.7 100 42 103
21147 McCreary Lake	Cumberland Rural 9 Appalachia 0.589 0.768 56 39 25.3 33 19 44.8
21149 McLean Green	River Urban 3 Non-Appalachia 0.703 0.919 37 21 42.6 26 13 60.7
21151 Madison Bluegrass Rural 4 Appalachia 0.639 0.819 166 102 27.5 106 54 40.2
21153 Magoffin Big	Sandy Rural 9 Appalachia 0.656 0.844 32 20 23.9 21 11 34
21155 Marion Lincoln	Trail Rural 6 Non-Appalachia 0.571 0.905 42 25 56.8 24 12 66.9
21157 Marshall Purchase Rural 7 Non-Appalachia 0.670 0.912 91 55 48.5 61 31 61.8
21159 Martin Big	Sandy Rural 8 Appalachia 0.500 0.692 26 15 32.8 13 4 NA
21161 Mason Buffalo	Trace Rural 6 Non-Appalachia 0.702 0.872 47 30 37.3 33 18 42.5
21163 Meade Lincoln	Trail Urban 1 Non-Appalachia 0.513 0.795 78 52 39.9 40 19 65.6
21165 Menifee Gateway Rural 9 Appalachia 0.654 0.808 26 17 47.3 17 11 47.3
21167 Mercer Bluegrass Rural 6 Non-Appalachia 0.674 0.935 46 26 32.1 31 16 38.6
21169 Metcalfe Barren	River Rural 9 Appalachia 0.667 0.792 24 12 70.4 16 6 70.4
21171 Monroe Barren	River Rural 9 Appalachia 0.605 0.868 38 24 36.6 23 13 45.6
21173 Montgomery Gateway Rural 6 Appalachia 0.736 0.887 53 32 46.7 39 20 65.5
21175 Morgan Gateway Rural 7 Appalachia 0.676 0.912 34 20 30.3 23 12 50.7
21177 Muhlenberg Pennyrile Rural 6 Non-Appalachia 0.684 0.842 95 61 37.5 65 36 54.7
21179 Nelson Lincoln	Trail Urban 1 Non-Appalachia 0.549 0.814 102 55 48.3 56 24 89.8
21181 Nicholas Bluegrass Rural 8 Appalachia 0.696 0.870 23 13 42.5 16 9 43.7
21183 Ohio Green	River Rural 6 Non-Appalachia 0.614 0.904 83 55 26.7 51 30 51.5
21185 Oldham Kipda Urban 1 Non-Appalachia 0.714 0.929 98 57 45.7 70 34 61.1
21187 Owen Northern	Kentucky Rural 8 Non-Appalachia 0.636 0.864 22 15 27.1 14 7 41.1
21189 Owsley Kentucky	River Rural 9 Appalachia 0.636 0.864 22 14 23.1 14 7 45.6
21191 Pendleton Northern	Kentucky Urban 1 Non-Appalachia 0.618 0.912 34 21 31.4 21 13 30.4
21193 Perry Kentucky	River Rural 7 Appalachia 0.505 0.825 103 74 25.3 52 29 40.8
21195 Pike Big	Sandy Rural 7 Appalachia 0.684 0.809 225 152 32.3 154 91 46.2
21197 Powell Bluegrass Rural 6 Appalachia 0.660 0.860 50 27 34.9 33 17 37.9
21199 Pulaski Lake	Cumberland Rural 5 Appalachia 0.614 0.850 153 93 33.2 94 45 60.7
21201 Robertson Buffalo	Trace Rural 8 Appalachia 0.800 1.000 5 3 46.8 4 2 54.5
21203 Rockcastle Cumberland	Valley Rural 7 Appalachia 0.725 0.825 40 22 42.2 29 13 61.6
21205 Rowan Gateway Rural 7 Appalachia 0.660 0.830 47 30 32.5 31 17 56.8
21207 Russell Lake	Cumberland Rural 9 Appalachia 0.524 0.786 42 26 27.4 22 9 NA
21209 Scott Bluegrass Urban 2 Non-Appalachia 0.683 0.921 63 35 39.7 43 18 69.2
21211 Shelby Kipda Urban 1 Non-Appalachia 0.629 0.835 97 49 56.2 61 20 115.7
21213 Simpson Barren	River Rural 6 Non-Appalachia 0.745 0.836 55 36 34.2 41 22 53.7
21215 Spencer Kipda Urban 1 Non-Appalachia 0.586 0.862 29 12 NA 17 4 NA
21217 Taylor Lake	Cumberland Rural 7 Non-Appalachia 0.535 0.733 101 61 34.7 54 26 51.6
21219 Todd Pennyrile Rural 8 Non-Appalachia 0.455 0.773 22 11 63.2 10 5 36.1
21221 Trigg Pennyrile Urban 3 Non-Appalachia 0.511 0.756 45 30 42 23 11 78.8
21223 Trimble Kipda Urban 1 Non-Appalachia 0.632 0.895 19 13 40.6 12 8 49.6
21225 Union Green	River Rural 6 Non-Appalachia 0.550 0.825 40 27 45.4 22 12 67.6
21227 Warren Barren	River Urban 3 Non-Appalachia 0.640 0.860 278 168 31.3 178 85 63.5
21229 Washington Lincoln	Trail Rural 8 Non-Appalachia 0.714 0.821 28 17 22.5 20 10 37.1
21231 Wayne Lake	Cumberland Rural 7 Appalachia 0.638 0.851 47 28 35.6 30 14 46.2
21233 Webster Green	River Urban 2 Non-Appalachia 0.643 0.857 28 20 25.9 18 11 28.7
21235 Whitley Cumberland	Valley Rural 7 Appalachia 0.632 0.832 95 57 30.5 60 31 51.4
21237 Wolfe Kentucky	River Rural 9 Appalachia 0.625 0.792 24 15 22.5 15 8 49.1
21239 Woodford Bluegrass Urban 2 Non-Appalachia 0.586 0.845 58 31 26.6 34 15 79.8
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R Script for data analysis 
# Jeremiah Martin 10719733 
# Capstone Project 
# Analysis of KCR data 
# Lung Cancer (NSCLC) - early stage - paterns/trends in definitive surgery 
 
 
# Open File 
# Macbook Pro 
load(file="/Users/jerrymartin/Dropbox/Academics/000 Masters/CPH 778 
Capstone/Data/kcr_nscl_0514.rda") 
# Macbook Pro - Parallels / Windows 
load(file="Z:/Dropbox/Academics/000 Masters/CPH 778 
Capstone/Data/kcr_nscl_0514.rda") 
# Home PC 
load(file="C:/Users/Jerry/Dropbox/Academics/000 Masters/CPH 778 
Capstone/Data/kcr_nscl_0514.rda") 
# Work PC 
load(file="C:/Users/MartinJT/Dropbox/Academics/000 Masters/CPH 778 
Capstone/Data/kcr_nscl_0514.rda") 
# Load Libraries 
 
library(gmodels) 
library(tableone) 
library(MASS) 
library(rattle) 
library(survival) 
library(choroplethr) 
library(ggplot2) 
 
# Copy the loaded dataset to a new table, n1 
n1 <- lung 
 
####### Data and Variable Cleanup ######### 
 
#  [1] Create Analytic Groups for this project 
# 
# Create the "clinically operable group" 
#This uses best available clinical data 
#giving the "benefit of the doubt" 
#Starts by assuming patient is operable 
#Then: Does the patient have mets? Mediastinal nodes? Unresectable T? 
n1$ClinOp <- 1 
n1$ClinOp[!(n1$TNMClinM %in% c("c0","cx=X"))] <- 0 
n1$ClinOp[n1$TNMClinN %in% c("c2","c2A","c2C","c3","c3A")] <- 0 
n1$ClinOp[n1$TNMClinT %in% c("c4","c4A")] <- 0 
 
 
# create a categorical variable form BestStageGrp to categorize less than III 
# This is "all comers" best stage divided into potentially operable vs not 
n1$BestStageClass <- factor(ifelse(n1$BestStageGrp %in% c("00", "12", "15", "32", 
"33"),1,0)) 
 
# Look at the "First Treatment Composite Code" and create to dummy classification 
variables 
# First is surgery of the primary site, ideal 
# Second is surgery or radiation of the primary site - any focused local therapy 
 
n1$surg <- factor(ifelse(n1$FstTrtCompCode %in% c(1,3,5,7,9,11,13,15),1,0)) 
n1$local <- factor(ifelse(n1$FstTrtCompCode %in% 
c(1,3,4,5,6,7,9,11,12,13,14,15),1,0)) 
 
 
#   [2] Clean up, categorize the input variables 
# Convert Race to a binary variable (overwhelming majority are white) 
n1$rwhite <- factor(ifelse(n1$Race1 == "1", 1,0)) 
 
#convert tumor size to numeric and recode 
n1$CSTumorSize <- as.numeric(n1$CSTumorSize) 
 
#Collapse case class (diagnosed at treating facility vs referred in) 
n1$caseclass.ref <- factor(ifelse(n1$CASECLASS %in% 
c(0,10,11,12,13,14,20,21,22),0,1)) 
 
#collapse histologic diagnosis field 
n1$histconf <- factor(ifelse(n1$DIAGCONFIRM %in% c(1,2,3),1,0)) 
 
#recode laterality where unspecified to NA 
n1$Laterality[n1$Laterality>2] <- NA 
n1$Laterality[n1$Laterality==0] <- NA 
n1$Laterality <- factor(n1$Laterality) 
 
#recode TUMOR_SIZE to missing where appropriate (>990) 
n1$TUMOR_SIZE <- as.numeric(n1$CSTumorSize) 
n1$TUMOR_SIZE[n1$TUMOR_SIZE>899] <- NA 
 
#recode Marital Status of "unknown" to NA 
n1$MARITALSTATUS[n1$MARITALSTATUS==9] <- NA 
n1$MARITALSTATUS <- factor(n1$MARITALSTATUS) 
 
#collapse insurance status 
n1$insurance[n1$PRIMARYPAYOR %in% c(1,2,10,99)] <- 0 #unknown, self-pay, 
uninsured 
n1$insurance[n1$PRIMARYPAYOR %in% c(20,21)] <- 1 #managed care, private insurance 
n1$insurance[n1$PRIMARYPAYOR %in% c(31,35)] <- 2 #medicaid 
n1$insurance[n1$PRIMARYPAYOR %in% c(60,61,62,63,64)] <- 3 #medicare 
n1$insurance[n1$PRIMARYPAYOR %in% c(65,66,67,68)] <- 4 #military, va, other govt 
n1$insurance <- factor(n1$insurance) 
 
#collapse smoking status 
n1$smoking[n1$Tobacco %in% c(1,2,3,4)] <- 1 # smoker, chew, other kinds 
n1$smoking[n1$Tobacco == 0] <- 0 # no smoking 
n1$smoking[n1$Tobacco == 9] <- NA # unknown 
n1$smoking <- factor(n1$smoking) 
 
#create county beale code variable 
n1$beale[n1$county %in% 
c(21015,21023,21029,21037,21077,21081,21103,21111,21117,21163,21179,21185,21191,2
1211,21215,21223)] <- 1  
n1$beale[n1$county %in% 
c(21015,21017,21019,21049,21067,21089,21101,21113,21209,21233,21239)] <- 2 
n1$beale[n1$county %in% 
c(21015,21047,21059,21061,21091,21093,21123,21149,21221,21227)] <- 3          
n1$beale[n1$county %in% c(21015,21073,21107,21151)] <- 4 
n1$beale[n1$county %in% c(21015,21145,21199)] <- 5          
n1$beale[n1$county %in% 
c(21015,21003,21005,21009,21033,21041,21043,21055,21065,21079,21085,21097,21127,2
1141,21155,21161,21167,21173,21177,21183,21197,21213,21225)] <- 6          
n1$beale[n1$county %in% 
c(21015,21001,21013,21021,21025,21035,21051,21069,21071,21075,21083,21095,21115,2
1121,21125,21137,21157,21175,21193,21195,21203,21205,21217,21231,21235)] <- 7 
n1$beale[n1$county %in% 
c(21015,21011,21027,21031,21087,21099,21135,21143,21159,21181,21187,21201,21219,2
1229)] <- 8          
n1$beale[n1$county %in% 
c(21015,21007,21039,21045,21053,21057,21063,21105,21109,21119,21129,21131,21133,2
1139,21147,21153,21165,21169,21171,21189,21207,21237)] <- 9            
31 
 
n1$beale <- factor(n1$beale) 
 
#create county rate of surgery variable 
n1$countyrate[n1$county %in% c(21131, 21063, 21105, 21115, 21219, 21039, 21001, 
21013, 21087, 21005, 21159, 21193, 21047, 21097, 21221, 21163, 21207, 21043, 
21139)] <- 1 
n1$countyrate[n1$county %in% c(21217, 21023, 21071, 21121, 21109, 21179, 21073, 
21225, 21111, 21025, 21027, 21123, 21021, 21101, 21119, 21069, 21017, 21155, 
21033)] <- 2 
n1$countyrate[n1$county %in% c(21015, 21145, 21037, 21045, 21239, 21215, 21113, 
21089, 21147, 21127, 21079, 21103, 21091, 21171)] <- 3 
n1$countyrate[n1$county %in% c(21035, 21059, 21051, 21107, 21199, 21183, 21099, 
21191, 21117, 21081, 21065, 21129, 21237, 21007, 21211, 21235, 21223)] <- 4 
n1$countyrate[n1$county %in% c(21187, 21189, 21231, 21151, 21227, 21233, 21093, 
21049, 21055, 21019, 21041, 21141, 21067, 21165, 21153, 21011, 21205)] <- 5 
n1$countyrate[n1$county %in% c(21197, 21003, 21029, 21075, 21169, 21143, 21157, 
21167, 21175, 21057, 21209, 21061, 21177, 21195, 21083, 21135, 21181)] <- 6 
n1$countyrate[n1$county %in% c(21085, 21161, 21149, 21229, 21185, 21053, 21095, 
21137, 21203, 21125, 21173, 21133, 21213, 21031, 21009, 21077, 21201)] <- 7 
n1$countyrate <- factor(n1$countyrate) 
 
#create a rural variable from beale data 
n1$rural <- factor(ifelse(n1$beale %in% c(1,2,3),0,1)) 
 
#convert remaining variables of interest to factors 
n1$Sex <- factor(n1$Sex) 
n1$Year_Diag <- factor(n1$Year_Diag) 
n1$county <- factor(n1$county) 
n1$APPAL <- factor(n1$APPAL) 
 
          
#   [3] Prepare survival data  
# Calculate survival dates: 
# subtract 5-digit day code for date of last contact from date of diagnosis 
# Create a survival in months variable 
 
n1$survdays <- n1$Date_LC-n1$Date_dx 
n1$survmos <- n1$survdays/30.4167 
 
 
#Create new datasets for analysis 
#lc = clinically operable lung group from ClinOp 
#lb = best clinical stage operable group 
lc <- subset(n1,n1$ClinOp == 1) 
lb <- subset(n1,n1$BestStageClass == 1) 
 
 
######## Create Table One ########## 
 
#  
# all variables of interest 
# inputs <- c("MARITALSTATUS", "rwhite", "Sex", "DiagAge", 
"CentralSequenceNumber",  
#             "Laterality", "histconf", "caseclass.ref", "insurance", 
#             "TNMClinT", "TNMClinN", "TNMClinM", "TNMClinStageGrp", 
"TUMOR_SIZE",  
#             "DerivedAJCC7StgGrp", "RXSummSurgPrimSite",  
#             "REASONNOSURG", "ReasonNoRad", "VITALSTAT", "smoking", 
"MenopauStatus",  
#             "FstTrtCompCode", "BestStageGrp", 
#             "Year_Diag", "county", "APPAL", "HS_Edu2010", 
"PctBelowPoverty2010",  
#             "ClinOp", "BestStageClass", "surg", "local") 
#  
#  
# inputs.factor <- c("MARITALSTATUS", "rwhite", "Sex", "CentralSequenceNumber",  
#                    "Laterality" , "histconf", "caseclass.ref", "insurance", 
#                    "TNMClinT", "TNMClinN", "TNMClinM", "TNMClinStageGrp",  
#                    "DerivedAJCC7StgGrp", "RXSummSurgPrimSite",  
#                    "REASONNOSURG", "ReasonNoRad", "VITALSTAT", "smoking", 
"MenopauStatus",  
#                    "FstTrtCompCode", "BestStageGrp", 
#                    "Year_Diag", "county", "APPAL",  
#                    "ClinOp", "BestStageClass", "surg", "local") 
 
# publication variables 
inputs <- c("MARITALSTATUS", "rwhite", "Sex", "DiagAge", "CentralSequenceNumber", 
            "Laterality", "histconf", "caseclass.ref", "insurance", 
            "TNMClinT", "TNMClinN", "TNMClinM", "TNMClinStageGrp", "TUMOR_SIZE", 
            "smoking", "BestStageGrp", 
            "Year_Diag", "APPAL", "beale", "rural", "HS_Edu2010", 
"PctBelowPoverty2010") 
 
 
inputs.factor <- c("MARITALSTATUS", "rwhite", "Sex", "CentralSequenceNumber", 
                   "Laterality" , "histconf", "caseclass.ref", "insurance", 
                   "TNMClinT", "TNMClinN", "TNMClinM", "TNMClinStageGrp", 
                   "smoking", "BestStageGrp", 
                   "Year_Diag","APPAL", "beale", "rural") 
 
 
 
### 
### Create Descriptive Table 1 
### 
 
#Table of county by surgery or local therapy 
#create maps using choroplethr 
 
table(lc$county, lc$surg) 
table(lc$county, lc$local) 
 
# #need to load county rates for surgery and local therapy 
# county <- data.frame(region = local_county$X1,value=local_county$X2) 
# county_choropleth(county, "Local Therapy", state_zoom = "kentucky") + 
scale_fill_brewer("Local Therapy",palette="Blues") 
#  
 
 
 
 
#Table 1a - Clinically "Benefit of doubt" best case, stratified by surgery vs 
none 
options(width=200) 
t1 <- CreateTableOne(vars=inputs, strata="surg", data=lc, factorVars = 
inputs.factor) 
print(t1, missing=T, quote = T, showAllLevels=T, format="fp",  
nonnormal=c("DiagAge", "CSTumorSize")) 
 
#Table 1b - Best staging available, stratified by surgery vs none 
t1 <- CreateTableOne(vars=inputs, strata="surg", data=lb, factorVars = 
inputs.factor) 
print(t1, missing=T, quote = T, showAllLevels=T, format="fp",  
nonnormal=c("DiagAge", "CSTumorSize")) 
 
#Table 1c - Clinically "Benefit of doubt" best case, stratified by local therapy  
vs none 
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t1 <- CreateTableOne(vars=inputs, strata="local", data=lc, factorVars = 
inputs.factor) 
print(t1, missing=T, quote = T, showAllLevels=T, format="fp",  
nonnormal=c("DiagAge", "CSTumorSize")) 
 
#Table 1d - Clinically "Benefit of doubt" best case, stratified by local therapy 
vs none 
t1 <- CreateTableOne(vars=inputs, strata="local", data=lb, factorVars = 
inputs.factor) 
print(t1, missing=T, quote = T, showAllLevels=T, format="fp",  
nonnormal=c("DiagAge", "CSTumorSize")) 
 
 
### Data Mining Techniques #### 
# Using rattle() package 
keepvars <- c("surg", "local", "MARITALSTATUS", "rwhite", "Sex", "DiagAge",  
              "Laterality", "caseclass.ref", "insurance", 
              "smoking", "county", "APPAL", 
              "Year_Diag", "beale", "HS_Edu2010", "PctBelowPoverty2010") 
lc.mine <- (lc[keepvars]) 
lb.mine <- (lb[keepvars]) 
 
rattle() 
 
### Multivariate Modelling ######## 
# Logistic Reression model  
# full <- glm(surg ~ MARITALSTATUS + rwhite + caseclass.ref + histconf + 
TUMOR_SIZE  
#             + insurance + smoking + Sex + DiagAge + CentralSequenceNumber + 
Laterality  
#             + APPAL + HS_Edu2010 + PctBelowPoverty2010, family="binomial", 
data=lc) 
 
# Usage: ldata is the dataframe of complete cases, replace the () with the source 
data of interest 
 
lkeep <- c("surg", "MARITALSTATUS", "rwhite", "Sex", "DiagAge",  
              "Laterality", "caseclass.ref", "insurance", 
              "smoking", "county", "APPAL", 
              "Year_Diag", "beale", "HS_Edu2010", "PctBelowPoverty2010") 
 
#Forward Selection using AIC (outcome surg) 
ldata <- na.omit(lc[lkeep]) 
null <- glm(surg~1, data=ldata, family="binomial") 
full <- glm(surg ~ ., data=ldata, family="binomial") 
step (null, scope=list(lower=null, upper=full), direction="forward") 
 
 
#This model is used to examine "local" as the outcome of interest 
lkeepl <- c("local", "MARITALSTATUS", "rwhite", "Sex", "DiagAge",  
           "Laterality", "caseclass.ref", "insurance", 
           "smoking", "county", "APPAL", 
           "Year_Diag", "beale", "HS_Edu2010", "PctBelowPoverty2010") 
 
#Forward Selection using AIC (outcome local) 
ldatal <- na.omit(lc[lkeepl]) 
null <- glm(local~1, data=ldatal, family="binomial") 
full <- glm(local ~ ., data=ldatal, family="binomial") 
step (null, scope=list(lower=null, upper=full), direction="forward") 
 
#Copy here the final stepwize model selected from above 
mylogit <-   glm(formula = surg ~ DiagAge + MARITALSTATUS + insurance + 
caseclass.ref +  
                   Year_Diag + smoking + Sex + rwhite + Laterality + 
PctBelowPoverty2010,  
                 family = "binomial", data = ldata) 
 
mylogit_local <- glm(formula = local ~ DiagAge + MARITALSTATUS + caseclass.ref +  
                       insurance + Sex + Year_Diag + PctBelowPoverty2010 + rwhite 
+  
                       beale, family = "binomial", data = ldatal) 
 
summary(mylogit) 
exp(cbind(OR = coef(mylogit), confint.default(mylogit))) 
 
summary(mylogit_local) 
exp(cbind(OR = coef(mylogit_local), confint.default(mylogit_local))) 
 
# ROC CURVES 
 
 
probs=predict(mylogit,lc,type=c("response")) 
lc$probs=probs 
library(pROC) 
g <- roc(surg ~ probs, data = lc, plot=T) 
g 
 
probl=predict(mylogit_local,lc,type=c("response")) 
lc$probl=probl 
library(pROC) 
g <- roc(local ~ probl, data = lc, plot=T) 
g 
 
 
#univariate odds ratios 
unimylogit <-   glm(formula = surg ~ APPAL , 
                 family = "binomial", data = ldata) 
summary(unimylogit) 
exp(cbind(OR = coef(unimylogit), confint.default(unimylogit))) 
 
 
 
 
 
####### Survival Analysis ######### 
lung.surv <- Surv(lc$survmos,lc$VITALSTAT==0) ~ lc$surg  
surv.fit <- survfit(lung.surv, conf.type="none") 
survdiff(lung.surv) 
plot(surv.fit, xmax=72, main="Kaplan-Meier estimates for Surgery vs None", 
     sub="Clinical best-case group", 
     xlab="Time (Months)", ylab="Survival", lwd=2, lty=2:1, cex=0) 
legend(x="topright", lwd=2, lty=1:2, legend=c("Surgery","No Surgery")) 
text(10,0.1, labels="Log-Rank p<0.001") 
print(surv.fit) 
 
 
lung.surv <- Surv(lb$survmos,lb$VITALSTAT==0) ~ lb$surg  
surv.fit <- survfit(lung.surv, conf.type="none") 
survdiff(lung.surv) 
plot(surv.fit, xmax=72, main="Kaplan-Meier estimates for Surgery vs None", 
     sub="Best available stage group", 
     xlab="Time (Months)", ylab="Survival", lwd=2, lty=2:1, cex=0) 
legend(x="topright", lwd=2, lty=1:2, legend=c("Surgery","No Surgery")) 
text(10,0.1, labels="Log-Rank p<0.001") 
print(surv.fit) 
 
lung.surv <- Surv(lc$survmos,lc$VITALSTAT==0) ~ lc$local  
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surv.fit <- survfit(lung.surv, conf.type="none") 
survdiff(lung.surv) 
plot(surv.fit, xmax=72, main="Kaplan-Meier estimates for Local Therapy vs None", 
     sub="Clinical best-case group", 
     xlab="Time (Months)", ylab="Survival", lwd=2, lty=2:1, cex=0) 
legend(x="topright", lwd=2, lty=1:2, legend=c("Local Therapy","No Local 
Therapy")) 
text(10,0.1, labels="Log-Rank p<0.001") 
print(surv.fit) 
 
 
lung.surv <- Surv(lb$survmos,lb$VITALSTAT==0) ~ lb$local  
surv.fit <- survfit(lung.surv, conf.type="none") 
survdiff(lung.surv) 
plot(surv.fit, xmax=72, main="Kaplan-Meier estimates for Local Therapy vs None", 
     sub="Best available stage group", 
     xlab="Time (Months)", ylab="Survival", lwd=2, lty=2:1, cex=0) 
legend(x="topright", lwd=2, lty=1:2, legend=c("Local Therapy","No Local 
Therapy")) 
text(10,0.1, labels="Log-Rank p<0.001") 
print(surv.fit) 
 
#univariate hazard ratios 
skeep <- c("surg","local", "MARITALSTATUS", "rwhite", "Sex", "DiagAge",  
           "Laterality", "caseclass.ref", "insurance", 
           "county", "APPAL", "countyrate", 
           "Year_Diag", "beale", "HS_Edu2010", "PctBelowPoverty2010", 
"VITALSTAT", "survmos") 
ls <- lc[skeep] #which dataset lc vs lb to use in the following computations 
 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$surg)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$local)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$beale)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$rural)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$APPAL)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$Sex)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$DiagAge)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$smoking)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$Year_Diag)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$HS_Edu2010)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$PctBelowPoverty2010)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$rwhite)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$caseclass.ref)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$insurance)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$countyrate)) 
summary(coxph(Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$MARITALSTATUS)) 
 
 
lung.surv2 <- Surv(ls$survmos,ls$VITALSTAT==0) ~ ls$surg+ ls$APPAL  + ls$Sex + 
ls$DiagAge + ls$HS_Edu2010 + ls$PctBelowPoverty2010 + ls$rwhite + 
ls$caseclass.ref + ls$insurance + ls$MARITALSTATUS 
coxph.fit <- coxph(lung.surv2) 
summary(coxph.fit) 
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